Metformin in chronic kidney disease: Time for a rethink

Peritoneal Dialysis International

Volumn 34, Issue 4, 2014, Pages 353-357

  Heaf, James ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Chronic kidney disease; Diabetes mellitus; Lactic acidosis; Metformin

Indexed keywords

HEMOGLOBIN A1C; METFORMIN; PHENFORMIN; ANTIDIABETIC AGENT;

BODY MASS; CHRONIC KIDNEY DISEASE; CREATININE CLEARANCE; DRUG CONTRAINDICATION; DRUG INTOXICATION; FIBRINOLYSIS; GLOMERULUS FILTRATION RATE; GLUCONEOGENESIS; GLYCEMIC CONTROL; HEART FAILURE; HEART INFARCTION; HUMAN; INSULIN SENSITIVITY; KETOACIDOSIS; KIDNEY FAILURE; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; UROSEPSIS; WEIGHT REDUCTION; CHEMICALLY INDUCED; COMPLICATION; CONTRAINDICATIONS; DIABETES MELLITUS, TYPE 2; RENAL INSUFFICIENCY, CHRONIC; RISK;

ACIDOSIS, LACTIC; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; RENAL INSUFFICIENCY, CHRONIC; RISK;

EID: 84925883671     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2013.00344     Document Type: Review

References (35)

1. Cohen RD, Woods HF. Clinical and biochemical aspects of lactic acidosis. Oxford: Blackwell Scientific Publications Ltd.; 1976
2. Cohen RD, Woods HF. Lactic acidosis revisited. Diabetes 1983;32:181-91.
3. Duong JK, Roberts DM, Furlong TJ, Kumar SS, Greenfield JR, Kirkpatrick CM, et al. Metformin therapy in patients with chronic kidney disease. Diabetes Obes Metab 2012; 14:963-5.
4. Lalau JD, Lemaire-Hurtel AS, Lacroix C. Establishment of a database of metformin plasma concentrations and erythrocyte levels in normal and emergency situations. Clin Druglnvestig 2011; 31:435-8.
5. Wang DS, Kusuhara H, Kato Y, Jonker JW, Schinkel AH, Sugiyama Y. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. MolPharmacol 2003; 63:844-8.
6. Lalau JD, Mourlhon C, Bergeret A, Lacroix C. Consequences of metformin intoxication. Diabetes Care 1998; 21:2036-7.
7. Dell'Aglio DM, Perino LJ, Kazzi Z, Abramson J, Schwartz MD, Morgan BW. Acute metformin overdose: examining serum pH, lactate level, and metformin concentrations in survivors versus nonsurvivors: a systematic review of the literature. Ann Emerg Med 2009; 54:818-23.
8. Graham GG, Punt J, Arora M, Day R0, Doogue MP, Duong JK, et al. Clinical pharmacokinetics of metformin. Clin Pharmacokinet 2011; 50:81-98.
9. Duong JK, Kumar SS, Kirkpatrick CM, Greenup LC, Arora M, Lee TC, etal. Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renalfunction. Clin Pharmacokinet 2013; 52:373-84.
10. Bergman U, Boman G, Wiholm BE. Epidemiology of adverse drug reactions to phenformin and metformin. Br Med J 1978; 2:464-6.
11. Chan NN, Brain HP, FeherMD. Metformin-associated lactic acidosis: a rare or very rare clinical entity? Diabet Med 1999; 16:273-81.
12. Moen MF, Zhan M, Hsu VD, Walker LD, Einhorn LM, Seliger SL, etal. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol 2009; 4:1121-7.
13. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359:1577-89.
14. Eurich DT, McAlister FA, Blackburn DFetal. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ 2007; 335:497.
15. Eurich DT, Tsuyuki RT, Majumdar SR, McAlister FA, Lewanczuk R, Shibata MC, et al. Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality. Trials 2009; 10:12.
16. Cusi K, Consoli A, DeFronzo RA. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996; 81:4059-67.
17. Pilger E, Schmid P, Goebel R. Effectofbiguanidetherapyon lactate metabolism during graded submaximalergometric testing. Acta MedAustriaca 1978; 5:91-5.
18. Watkins PJ, Smith JS, Fitzgerald MG, Malins JM. Lactic acidosis in diabetes. Br Med J1969; 1:744-7.
19. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2010; CD002967.
20. Brown JB, Pedula K, Barzilay J, Herson MK, Latare P. Lactic acidosis rates in type 2 diabetes. Diabetes Care 1998; 21:1659-63.
21. Heaf JG, van Biesen W. Metformin and chronic renal impairment: a story of choices and ugly ducklings. Clin Diab 2011; 29:97-101.
22. Bodmer M, Meier C, Krahenbuhl S, Jick SS, Meier CR. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes Care 2008; 31:2086-91.
23. Aguilar C, Reza A, Garcia JE, Rull JA. Biguanide related lactic acidosis: incidence and risk factors. Arch Med Res 1992;23:19-24
24. Tahrani AA, Varughese GI, Scarpello JH, Hanna FW. Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated? BMJ 2007; 335:508-12.
25. Holstein A, Nahrwold D, Hinze S, Egberts EH. Contraindications to metformin therapy are largely disregarded. Diabet Med 1999; 16:692-6.
26. Mani MK. Metformin in rena I failure—weigh the evidence. Nephrol Dial Transplant 2009; 24:2287-8.
27. Lambert H, Isnard F, Delorme N, Claude D, Bollaert PE, Strączek J, etal. Physiopathological approach to pathological hyperlactatemia in the diabetic patient. Value of blood metformin. Ann FrAnesth Reanim 1987; 6:88-94.
28. Stades AM, Heikens JT, Erkelens DW, Holleman F, Hoekstra JB. Metformin and lactic acidosis: cause or coincidence? A review of case reports. J Intern Med 2004; 255:179-87.
29. Lalau JD, Race JM. Lactic acidosis in metformin therapy: searchingforalinkwith metforminin reports of 'metform-in-associated lactic acidosis.' Diabetes Obes Metab 2001; 3:195-201.
30. van Berlo-van de Laar IR, Vermeij CG, Doorenbos CJ. Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements. J Clin Pharm Ther 2011; 36:376-82.
31. Nyirenda MJ, Sandeep T, Grant I, Price G, McKnight JA. Severe acidosis in patients taking metformin—rapid reversal and survival despite high APACHE score. Diabet Med 2006; 23:432-5.
32. Herrington WG, Levy JB. Metformin: effective and safe in renal disease? Int Urol Nephrol 2008; 40:411-7.
33. Al-Hwiesh A, Abdul-Rahman I, Larbi E, Divino-Filho JC, Al-Muhanna F, Gupta K. Metformin in peritoneal dialysis: a pilot experience. Perit Dial Int 2014. [Epub ahead of print]
34. Nye HJ, Herrington WG. Metformin: the safest hypogly-caemicagentin chronic kidney disease? Nephron Clin Pract 2011; 118:c380-3.
35. Stacul F, van der Molen AJ, Reimer P, Webb JA, Thomsen HS, Morcos SK, Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR), et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011; 21:2527-41.